Responses
Clinical/translational cancer immunotherapy
Original research
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Compose a Response to This Article
Other responses
No responses have been published for this article.